Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,432.64
(
-0.91%
)
US TECH 100
28,465.60
(
-1.13%
)
Dow Jones
49,606.08
(
-0.91%
)
Brent Oil
106.75
(
2.46%
)
Bitcoin
79,091.63
(
-2.42%
)
News Focus
News Focus
Post# of 257570
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: stockbettor post# 89042

Monday, 08/09/2010 6:59:39 PM

Monday, August 09, 2010 6:59:39 PM

Post# of 257570
“When you think about Copaxone, many people try to equate it to Lovenox. It is much, much different—vastly more complex—than Lovenox will ever be. We have not characterized it. We don't believe it can be fully characterized."

Maybe indeed Teva's capability of full characterization isn't that great.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today